Featured Research

from universities, journals, and other organizations

Impaired Fetal Growth Increases Risk Of Asthma

Date:
October 13, 2009
Source:
Karolinska Institutet
Summary:
Children born with low birth weight are at a higher risk of developing asthma later in life. The study is based on data on the incidence of asthma in 10,918 twins from the Swedish Twin Registry.

A new study from Karolinska Institutet shows that children born with low birth weight are at a higher risk of developing asthma later in life. The study, which is published in the journal Pediatrics, is based on data on the incidence of asthma in 10,918 twins from the Swedish Twin Registry.

Questionnaire data on asthma in 9- and 12- year old twins was linked to the national Swedish Medical Birth Registry which records, amongst other data, birth weight and gestational age (i.e. how long into the pregnancy the baby is born). Since twins have the same gestational age and share DNA, uterine environment and conditions of early infancy, twin studies are an excellent way to examine the relationship between foetal growth and childhood disease.

"Our study shows that there's a distinct correlation between foetal growth and asthma that is independent of gestational age and environmental or genetic factors," says Catarina Almqvist Malmros, paediatrician and Assistant professor at the Department of medical epidemiology and biostatistics, Karolinska Institutet.

According to the WHO some 300 million people currently suffer from asthma. It is the most common chronic disease among children, and the number of children with the condition has risen steadily during the last decades. At the same time, an increasing number of children are being born with a low birth weight, a possible symptom of malnutrition in the womb. The study suggests that impaired foetal growth affects lung development.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ortqvist et al. Familial Factors Do not Confound the Association Between Birth Weight and Childhood Asthma. Pediatrics, 2009; 124 (4): e737 DOI: 10.1542/peds.2009-0305

Cite This Page:

Karolinska Institutet. "Impaired Fetal Growth Increases Risk Of Asthma." ScienceDaily. ScienceDaily, 13 October 2009. <www.sciencedaily.com/releases/2009/10/091012135510.htm>.
Karolinska Institutet. (2009, October 13). Impaired Fetal Growth Increases Risk Of Asthma. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/10/091012135510.htm
Karolinska Institutet. "Impaired Fetal Growth Increases Risk Of Asthma." ScienceDaily. www.sciencedaily.com/releases/2009/10/091012135510.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins